Keldoc Sas

Keldoc is an online platform that enables patients to easily schedule medical appointments with healthcare professionals across various specialties, enhancing accessibility to healthcare services. Keldoc is an online service that connects patients with healthcare providers for appointment scheduling. Founded in 2012 in Paris, France, Keldoc has completed 2 deals to date, with the most recent funding round occurring on July 19, 2014. In this round, Keldoc raised EUR 750,000 from lead investor Alven Capital Partners.

The company's valuation post-funding stands at EUR 4. 36 million. The founder, Marina Ramos, has a history of involvement in healthcare technology ventures, although specific details about other companies were not provided. Keldoc offers a comprehensive online platform that facilitates the scheduling of medical appointments.

Their core product allows patients to search for healthcare professionals across various specialties, enabling users to book consultations directly through the website. The service is designed to improve accessibility to healthcare by providing a streamlined interface for finding and connecting with doctors, thus addressing the common challenge of appointment scheduling in the medical field. The platform caters to a diverse client base, including individual patients seeking medical attention and healthcare providers looking to manage their appointment systems more efficiently. These services are primarily available in the French market, serving urban and rural populations alike, thereby ensuring comprehensive healthcare access.

Keldoc generates revenue through a structured transaction model that includes partnerships with healthcare providers and possibly subscription services for users. The platform operates on a commission basis, charging healthcare professionals for each appointment booked through the site. This transaction model extends to business-to-business relationships, where practices may subscribe to premium services for enhanced visibility or management tools. While specific pricing plans for services are not disclosed, the structure suggests that the firm capitalizes on both direct-to-consumer and B2B channels, ensuring multiple revenue streams while enhancing patient engagement in the healthcare ecosystem.

In July 2014, Keldoc raised EUR 750,000 in venture funding from Alven Capital Partners and business angels, valuing the company at EUR 4. 36 million post-money. The funding will support future initiatives, including the design and launch of new products aimed at enhancing user experience. Keldoc is also looking to expand its services into additional geographic regions within Europe, although specific markets have yet to be identified.

The funds will facilitate these expansions and the development of new features to further improve the platform's functionality.